September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
Bariatric Surgery: Bypass, Band, or Sleeve at 2 Years
November 4th 2014As the number of bariatric surgeries increase, clinicians require more and better data about its long-term outcomes. As we know, as more people take a medication or undergo a surgical procedure, the better the quality of the collective data. It's the strength in numbers concept. In the case of bariatric surgery, many clinicians have questions about treatment failure rates and they suspect that reports of sustained weight loss may be overly optimistic.
Defining Treatment Options for Obese Asthmatic Patients
Looking at patients with asthma it can be easy to group them all together for treatment options. Recent studies have shown that that may not be the best way to approach helping people dealing with both obesity and asthma.
FDA Approves Once-Daily Oral Combination Treatment for Type 2 Diabetes
October 30th 2014AstraZeneca today announced that the US Food and Drug Administration has approved once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2 diabetes mellitus.
Regular Visits with Provider Key to Patients Maintaining Weight Loss from Lifestyle Modifications
October 26th 2014The 2013 revision of guidelines on managing overweight and obesity in adults suggests that providers and patients set a goal of a sustained weight loss of 3-5% of baseline body weight to obtain improvements in triglycerides, blood glucose, HbA1c, and the risk of developing type 2 diabetes mellitus.
Diabetic Kidney Disease: New Consensus Document
October 22nd 2014Prompted by almost-epidemic rates of diabetes in the United States and globally, the American Diabetes Association recently convened a consensus panel to examine diabetic kidney disease, one of the most frequent complications associated with diabetes.
Tales of the Anion Gap, Part III: Case Examples
October 21st 2014Calculation and interpretation of the anion gap is extremely useful in the evaluation and treatment of the patient with metabolic acidosis. In this installment, we look at case examples involving patients with multiple sclerosis and urosepsis; COPD, diabetes, and renal failure; and type 1 diabetes.
Study: Immune System Protein Has Regulatory Function in Brain
Immune system proteins play a role in regulating the number of neural synapses, a research team from Princeton University and the University of California-San Diego report. The finding could mean that one of these proteins-known as major histocompatibility complex class I (MHCI) could play a significant role in Alzheimer's disease, type II diabetes and autism.
USPSTF Seeks Public Input on Screening Guidelines
The US Preventive Services Task Force (USPSTF) recently released a draft version of screening recommendations for abnormal glucose and type 2 diabetes mellitus in adults who are at increased risk for diabetes, and is seeking public input on the suggestions.
Making Bariatric Surgery Available to More Patients and Identifying Those Likely to Benefit the Most
October 8th 2014Researchers compared outcomes from bariatric surgery with those achieved through medical weight management in patients with diabetes to determine the effectiveness of bariatric surgery in patients with BMI less than 35. They also evaluated a potential biomarker for identifying patients likely to experience the best surgical outcomes.